Procter & Gamble (PG) PT Raised to $161 at Stifel

Stifel analyst Mark Astrachan raised the price target on Procter & Gamble (NYSE: PG) to $161.00 (from $157.00) while maintaining a Hold rating.

The analyst commented: "We view P&G shares as fairly valued near current levels, though lift our price target slightly to $161, 16x F2026E EBITDA. First-time F2025 guidance is likely to be consistent with the company’s long-term algorithm – organic sales growth above the global market (approximating 3%-5% growth, compared to current market growth of low-single-digits and consensus of 4%) and mid-to-high single-digit EPS growth (consensus of 6%). Nearer-term we anticipate F4Q24 organic sales growth similar to ~3% growth in F3Q24 reflecting solid volume growth in the large majority of markets, with weakness in Mainland China (sales down 10% in F3Q24) to continue for an additional 1-2 quarters, and with contribution from pricing also lessening."

You May Also Be Interested In

• Alphabet added to Dow Jones Industrial Average, Verizon dropped
• Alaska Air (ALK) PT Raised to $62 at UBS on Updated Q2 Estimates
• Southwest (LUV) PT Raised to $61 at UBS Ahead of Q2 Print